Cite
HARVARD Citation
Wedemeyer, H. et al. (2021). Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry. Liver international. pp. 949-955. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wedemeyer, H. et al. (2021). Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry. Liver international. pp. 949-955. [Online].